可切除食管癌：手术作为主要治疗方法并非答案，那么，什么是答案以及为何如此？ - Suppr

Suppr

超能文献

Resectable esophageal cancer: surgery as primary therapy is not the answer, but then, what is and why?

作者信息

Ajani Jaffer A

出版信息

J Clin Oncol. 2010 May 20;28(15):e243-4; author reply e245. doi: 10.1200/JCO.2009.26.7591. Epub 2010 Apr 5.

DOI:10.1200/JCO.2009.26.7591

PMID:20368554

Abstract

摘要

相似文献

Resectable esophageal cancer: surgery as primary therapy is not the answer, but then, what is and why?可切除食管癌：手术作为主要治疗方法并非答案，那么，什么是答案以及为何如此？

J Clin Oncol. 2010 May 20;28(15):e243-4; author reply e245. doi: 10.1200/JCO.2009.26.7591. Epub 2010 Apr 5.

[Problematic results of a randomized study of neoadjuvant radiochemotherapy of operable esophageal carcinoma].[可手术食管癌新辅助放化疗随机研究的问题结果]

Strahlenther Onkol. 2001 Jul;177(7):372-3.

Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.术前同步放化疗后行食管癌手术。

Ann Thorac Cardiovasc Surg. 2002 Jun;8(3):123-30.

Combined modality therapy of esophageal cancer: changes in the standard of care?食管癌的综合治疗：治疗标准的变化？

Ann Surg Oncol. 2004 Jul;11(7):641-3. doi: 10.1245/ASO.2004.04.907. Epub 2004 Jun 14.

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.仅新辅助化疗后的病理完全缓解能显著提高可切除食管鳞状细胞癌患者的长期生存率：术前化疗与单纯手术的随机对照试验最终报告

Cancer. 2001 Jun 1;91(11):2165-74.

Esophageal preservation--the management of esophageal cancer with concurrent radiation and chemotherapy.食管保留——同步放化疗治疗食管癌

Endoscopy. 1993 Nov;25(9):664-9. doi: 10.1055/s-2007-1010428.

Paclitaxel in the treatment of esophageal cancer.紫杉醇在食管癌治疗中的应用

Semin Oncol. 1999 Feb;26(1 Suppl 2):106-8.

[Progress of postoperative adjuvant therapies for esophageal cancer].[食管癌术后辅助治疗的进展]

Gan To Kagaku Ryoho. 2002 Dec;29(13):2475-80.

Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline.可切除食管癌的术前或术后治疗：更新的实践指南。

Clin Oncol (R Coll Radiol). 2010 May;22(4):250-6. doi: 10.1016/j.clon.2010.02.005.

Neoadjuvant therapy of esophageal cancer.食管癌的新辅助治疗。

Surg Oncol Clin N Am. 1997 Oct;6(4):723-40.

引用本文的文献

Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer.原发性肿瘤切除可能改善转移性胸段食管癌的预后。

Sci Rep. 2025 Jan 24;15(1):3054. doi: 10.1038/s41598-025-85419-y.

Evaluation of tumor regression by neoadjuvant chemotherapy regimens for esophageal adenocarcinoma: a systematic review and meta-analysis.新辅助化疗方案治疗食管腺癌的肿瘤退缩评估：系统评价和荟萃分析。

Dis Esophagus. 2023 Jan 28;36(2). doi: 10.1093/dote/doac058.

Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.预测食管癌患者术前放化疗后病理完全缓解的临床参数模型。

Ann Oncol. 2012 Oct;23(10):2638-2642. doi: 10.1093/annonc/mds210. Epub 2012 Jul 24.

Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.cT2N0M0 期食管癌的联合治疗模式：德克萨斯大学 M.D.安德森癌症中心的经验。

Cancer. 2011 Mar 1;117(5):925-30. doi: 10.1002/cncr.25651. Epub 2010 Oct 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验